Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Syngene Intl Share Price
Syngene International Ltd.
₹465.80
3.95(0.86%)
Invest in SYNGENE with up to 4.00x margin.
Trade with MTF25th May 2026 | 11:11 AM
NSE : SYNGENE
Open Free Demat Account
Syngene Intl Performance
Price Movement
₹465.80
₹464.10
₹472.00
↘ Today's Low↗ Today's High
1 Year Performance
₹465.80
₹380.00
₹728.60
↘ 52 Week Low↗ 52 Week High
Markets Today
High₹472.00
Low₹464.10
Open at₹467.00
Prev Close₹461.85
Volumes1.77 L
Avg Price₹467.97
Lower Circuit₹369.50
Upper Circuit₹554.20
Historical Performance
3M High₹518.55
3M Low₹380.00
1 Yr High₹728.60
1 Yr Low₹380.00
3 Yr High₹960.60
3 Yr Low₹380.00
5 Yr High₹960.60
5 Yr Low₹380.00
Syngene Intl Fundamentals
Market Cap
High in industry
18,813 Cr.
PE Ratio (TTM)
High in industry
59.40
Dividend Yield
Below industry Median
0.30
Net Profit TTM
36% decr over last year
316.70
Net Profit Growth
36% decr over last year
316.70
PEG Ratio
Negative PEG TTM
-1.60
ROE
38% decr over last year
6.54
Operating Revenue TTM
3,738.70
Operating Revenue Growth
2.6% incr over last year
Book Value
Above industry Median
4
MFI
MFI strongly Overbought
90.64
RSI
RSI is mid-range
57.53
EPS (TTM)
7.87
Debt to Equity
0
Face Value
10
Operating Profit Margin Qtr.
24.11
Operating Profit Qtr.
303.40
Net Profit Qtr.
147.90
Operating Revenue Qtr.
1,036.50
PB Ratio
4
Syngene Intl Financials
*All values are in Rs. Cr
Loading chart...
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 960 | 834.40 | 830.10 | 799.30 | 948.40 |
| Operating Expense | 675.70 | 649.70 | 652.60 | 631.20 | 638.40 |
| Operating Profit | 284.30 | 184.70 | 177.50 | 168.10 | 310 |
| Depreciation | 95.30 | 97.10 | 100.10 | 94.60 | 89.60 |
| Interest | 6.50 | 6.20 | 7.40 | 5.90 | 10.10 |
| Tax | 48.50 | 13.60 | 18 | 10.20 | 54.30 |
| Net Profit | 148.20 | 16.50 | 66.20 | 74 | 174.40 |
Syngene Intl Technicals
Syngene International Ltd. EMA & SMA
₹465.80
-5.55 (-1.18%)
↗ Bullish Moving Average
10
↘ Bearish Moving Average
6
Day EMA5 ₹466.7
Day EMA10 ₹463.8
Day EMA12 ₹462
Day EMA20 ₹454.7
Day EMA26 ₹450.5
Day EMA50 ₹449.8
Day EMA100 ₹481.4
Day EMA200 ₹541.8
Syngene Intl Support and Resistance
Resistance
First Resistance₹479.88
Second Resistance₹488.42
Third Resistance₹497.73
Support
First Support₹462.03
Second Support₹452.72
Third Support₹444.18
Technical Indicators
Day RSI57.53
Day MFI90.64
Day ADX35.93
Day Commodity Channel Index65.10
William-53.24
Day MACD11.52
Day MACD Signal Line11.48
Day ATR21.47
Day ROC125-28.81
Day ROC217.96
Syngene Intl Shareholding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 52.7 | 52.7 | 52.7 | 52.7 | 52.7 | 52.7 |
| FII | 20.6 | 19.5 | 16.5 | 16.3 | 15 | 13.9 |
| DII | 19.6 | 21.5 | 24.1 | 24.6 | 25.8 | 26.5 |
| Public | 6.8 | 6 | 6.4 | 6.1 | 6.2 | 6.7 |
Syngene Intl Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 6.07 L | 13.56 L | 44.79% |
| Week | 4.7 L | 12.19 L | 38.55% |
| 1 Month | 11.8 L | 48.1 L | 24.53% |
| 6 Month | 7.1 L | 18.31 L | 38.78% |
Syngene Intl SWOT Analysis
Strengths9
Weakness13
Opportunity1
Threats0
Benjamin Graham Value Screen
PEG lower than Industry PEG
Overbought by Money Flow Index (MFI)
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Increasing Revenue every quarter for the past 3 quarters
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
Syngene Intl Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 25 Jun, 2026 | 1.25 | FINAL | 26 Jun, 2026 | Equity Share |
| 27 Jun, 2025 | 1.25 | FINAL | 27 Jun, 2025 | Equity Share |
| 28 Jun, 2024 | 1.25 | FINAL | 28 Jun, 2024 | Equity Share |
| 30 Jun, 2023 | 0.5 | FINAL | 30 Jun, 2023 | Equity Share |
| 30 Jun, 2022 | 0.5 | FINAL | 01 Jul, 2022 | Equity Share |
| 30 Jun, 2022 | 0.5 | SPECIAL | 01 Jul, 2022 | Equity Share |
| 16 Jul, 2019 | 0.5 | FINAL | 17 Jul, 2019 | Equity Share |
| 17 Jul, 2018 | 1 | FINAL | 18 Jul, 2018 | Equity Share |
| 20 Jul, 2017 | 1 | FINAL | 21 Jul, 2017 | Equity Share |
| 17 Mar, 2016 | 1 | INTERIM | 19 Mar, 2016 | Equity Share |
Syngene Intl Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,699.90 | ₹724.95 | ₹953.50 | ₹1,145.70 | ₹4,689.70 | ₹519.30 |
| % Change | 0.91% | 7.66% | 0.39% | 3.13% | -0.96% | -0.14% |
| Revenue TTM (₹ Cr) | ₹1,403.18 | - | ₹1,598.19 | ₹649.50 | ₹935 | ₹4,359.02 |
| Net Profit TTM (₹ Cr) | ₹185.12 | - | ₹206.20 | ₹115.38 | ₹257.90 | ₹255.19 |
| PE TTM | 57.20 | - | 78.90 | 43.30 | 43.40 | 31.80 |
| 1 Year Return | 63.07 | 9.63 | 103.31 | 111.14 | -2.21 | -6.77 |
| ROCE | 31.54 | 34.78 | 34.76 | 15.60 | - | 11.40 |
Similar Stocks
BLUEJET
Blue Jet Healthcare Ltd
₹ 445.35
+0.97%
CONCORDBIO
Concord Biotech Ltd.
₹ 1156.70
+0.29%
AARTIPHARM
Aarti Pharmalabs Ltd.
₹ 727.80
+2.06%
SUPRIYA
Supriya Lifescience Ltd.
₹ 783.45
+1.21%
ALIVUS
Alivus Life Sciences Ltd.
₹ 1041.50
+0.24%
COHANCE
Cohance Lifesciences Ltd.
₹ 428.75
+2.44%
ERIS
Eris Lifesciences Ltd.
₹ 1345.10
+0.10%
APLLTD
Alembic Pharmaceuticals Ltd.
₹ 757.50
+0.24%
SPARC
Sun Pharma Advanced Research Company Ltd.
₹ 226.41
+7.93%
STAR
Strides Pharma Science Ltd.
₹ 1176.60
+2.03%
GRANULES
Granules India Ltd.
₹ 760.30
+1.11%
FDC
FDC Ltd.
₹ 369.70
-0.95%
SHILPAMED
Shilpa Medicare Ltd.
₹ 510.85
+4.20%
JUBLPHARMA
Jubilant Pharmova Ltd.
₹ 970.00
-3.61%
CAPLIPOINT
Caplin Point Laboratories Ltd.
₹ 2067.00
+1.92%
MARKSANS
Marksans Pharma Ltd.
₹ 218.90
+3.32%
SANOFI
Sanofi India Ltd.
₹ 3159.40
-0.12%
PGHL
Procter & Gamble Health Ltd.
₹ 5601.00
+0.86%
JSLL
Jeena Sikho Lifecare Ltd.
₹ 628.00
-3.35%
FAQ's on SYNGENE
What is the current share price of Syngene International Ltd.?
As of 6 June 2025 at 10:01 AM, the share price for Syngene International Ltd. is ₹ 465.8 on the NSE and ₹ 465.7 on the BSE. (Note: Prices are dynamic and update frequently during market hours).
What is the Market Capitalization of Syngene International Ltd.?
Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Syngene International Ltd. is approximately ₹ 18813 Cr.
What are the PE and PB ratios for Syngene International Ltd.?
Based on recent data, the Price-to-Earnings (PE) ratio for Syngene International Ltd. is 59.4, and the Price-to-Book (PB) ratio is 4.
What is the 52-Week High and Low for Syngene International Ltd.?
Over the past 52 weeks, the highest price reached by Syngene International Ltd. shares was ₹ 728.6, and the lowest price was ₹ 380.
What is the current dividend yield for Syngene International Ltd.?
As of 6 June 2025, the dividend yield for Syngene International Ltd. is 0.3%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.
Who are the major shareholders of Syngene International Ltd.?
Significant shareholdings in Syngene International Ltd. typically include entities such as:
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
- Promoter
- Mutual Funds
- FII
- Public
- Other Institutions
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of Syngene International Ltd. in the Pharmaceuticals & Biotechnology sector?
In the Pharmaceuticals & Biotechnology sector, Syngene International Ltd. is often compared with other major players such as
Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.
What is the latest dividend information for Syngene International Ltd.?
Syngene International Ltd. last declared a FINAL dividend of ₹ 1.25 per share for the financial period ending 2026. The record date was set as 2026-06-25, and the payment was/is scheduled around 2026-06-25. For the most current dividend announcements, refer to official company filings.
What is the shareholding pattern for Syngene International Ltd.?
As per the filings for the quarter ending Mar 2026, the approximate shareholding pattern for Syngene International Ltd. is:
- Promoters: 52.7%
- Domestic Institutional Investors (DII): 26.5%
- Foreign Institutional Investors (FII): 13.9%
- Others (including Public): 0.2%
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy